Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues.

Details

Serval ID
serval:BIB_9DFB88E54072
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues.
Journal
Journal of Virology
Author(s)
Velin D., Fotopoulos G., Kraehenbuhl J.P., Acha-Orbea H.
ISSN
0022-538X (Print)
ISSN-L
0022-538X
Publication state
Published
Issued date
1999
Peer-reviewed
Oui
Volume
73
Number
2
Pages
1729-1733
Language
english
Abstract
Many mucosal pathogens invade the host by initially infecting the organized mucosa-associated lymphoid tissue (o-MALT) such as Peyer's patches or nasal cavity-associated lymphoid tissue (NALT) before spreading systemically. There is no clear demonstration that serum antibodies can prevent infections in o-MALT. We have tested this possibility by using the mouse mammary tumor virus (MMTV) as a model system. In peripheral lymph nodes or in Peyer's patches or NALT, MMTV initially infects B lymphocytes, which as a consequence express a superantigen (SAg) activity. The SAg molecule induces the local activation of a subset of T cells within 6 days after MMTV infection. We report that similar levels of anti-SAg antibody (immunoglobulin G) in serum were potent inhibitors of the SAg-induced T-cell response both in peripheral lymph nodes and in Peyer's patches or NALT. This result clearly demonstrates that systemic antibodies can gain access to Peyer's patches or NALT.
Keywords
Animals, Antibodies, Viral/immunology, Antigens, Viral/immunology, Immunity, Mucosal, Immunoglobulin G/immunology, Lymphoid Tissue/immunology, Mammary Tumor Virus, Mouse/immunology, Mice, Mucous Membrane/immunology, Superantigens/immunology
Pubmed
Web of science
Create date
24/01/2008 15:48
Last modification date
20/08/2019 16:04
Usage data